Back to Search Start Over

Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patients.

Authors :
Hugue, V.
Kandoussi, M.
Parra, H. J.
Dracon, M.
Fruchart, J. C.
Tacquet, A.
Cachera, C.
Source :
Nephrology Dialysis Transplantation; 1996, Vol. 11 Issue 5, p825-829, 5p
Publication Year :
1996

Abstract

Background To examine the possible alteration in Lp(a) composition, protein and lipid contents of Lp(a) were determined in 10 haemodialysis patients (HD) matched with 10 controls (C) fox apo(a) phenotypes. Methods All subjects (HD and C) had Lp(a) concentrations greater than 30 mg/dl (mean±SD : 82.3±41.4 vs 49.3±22.5 mg/dl), a concentration which has been determined to be associated with an elevated cardiovascular risk. Apo(a)-containing particles were isolated by immunoaffinity chromatography using a monoclonal anti-apo(a) antibody. Results The molar concentrations of lipid and protein constituents of immunoaffinity isolated Lp(a) were expressed as number of moles per mole of apo(a). Lp(a) from HD patients were significantly richer in apo Clll (P<0.05) and triglycerides (TG) (P<0.05), compared to those of controls. Molar ratios of apo B, apo E, cholesterol and phospholipids per apo(a)-containing particles were in the same range in both groups. Conclusions Lp(a) from HD patients is characterized by an elevated content in TG and apo Clll in comparison with those of controls. Further studies are needed to evaluate in HD patients the contribution of changes in Lp(a) composition towards the metabolism of these particles. [ABSTRACT FROM PUBLISHER]

Details

Language :
English
ISSN :
09310509
Volume :
11
Issue :
5
Database :
Complementary Index
Journal :
Nephrology Dialysis Transplantation
Publication Type :
Academic Journal
Accession number :
82414908
Full Text :
https://doi.org/10.1093/oxfordjournals.ndt.a027406